Abstract
Gene amplification is a mechanism whereby cultured animal cells and human tumours become resistant to cancer chemotherapeutic agents. This review of studies from the authors' laboratory describes properties of the acquisition of resistance to methotrexate in cultured mammalian cells by virtue of amplification of the dihydrofolate reductase gene. These properties result in a heterogeneous cell population with respect to many cell properties, including the number and stability of the amplified genes. Gene amplification results from overreplication of DNA in a single cell cycle as a result of inhibition of DNA synthesis. The cells surviving such overreplication constitute a heterogeneous population with multiple chromosomal changes, including partial or complete endoreduplication of chromosomes, as well as a variety of chromosomal rearrangements. A similar phenomenon may underlie the generation of aneuploidy in tumours, their malignant progression, and the generation of heterogeneity in the tumour cell population.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional information
Delivered at the Joint Meeting of the British Association for Cancer Research at the Royal Society of Medicine (Section of Oncology), Nov. 22-23, 1984.
Rights and permissions
About this article
Cite this article
Schimke, R., Hill, A. & Johnston, R. Fifth Gordon Hamilton-Fairley memorial lecture. Methotrexate resistance and gene amplification: An experimental model for the generation of cellular heterogeneity. Br J Cancer 51, 459–465 (1985). https://doi.org/10.1038/bjc.1985.66
Issue Date:
DOI: https://doi.org/10.1038/bjc.1985.66
This article is cited by
-
Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein–Barr virus reactivation
Leukemia (2003)
-
Rates of generation of methotrexate-resistant variants in cells temperature-sensitive for malignant transformation
Somatic Cell and Molecular Genetics (1988)
-
Can cancer chemotherapy enhance the malignant behaviour of tumours?
CANCER AND METASTASIS REVIEW (1987)